The companies reported that a lower dose of the vaccine had a 90.7 percent efficacy rate in preventing symptomatic Covid-19 in a clinical trial.
The companies reported that a lower dose of the vaccine had a 90.7 percent efficacy rate in preventing symptomatic Covid-19 in a clinical trial.